Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
104 studies found for:    Open Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects"
Show Display Options
Rank Status Study
21 Not yet recruiting Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy
Condition: Pain, Postoperative
Interventions: Drug: Morphine;   Drug: Oxycodone
22 Recruiting Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Conditions: Adverse Drug Event;   Adverse Drug Reaction;   Chinese Medicine;   Anaphylactic Reaction
Intervention: Drug: Breviscapine Powder-Injection
23 Recruiting Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Conditions: Safety Surveillance;   Adverse Drug Events;   Adverse Drug Reactions;   Severe Adverse Events;   Severe Adverse Reactions
Intervention: Drug: Compound Kuh-seng Injection
24 Recruiting Reduction of Adverse Drug Events and Readmissions
Condition: Pharmacogenomic Testing for Medication Management
Intervention:
25 Recruiting Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
Conditions: Adult Hepatocellular Carcinoma;   Recurrent Hepatocellular Carcinoma;   Adverse Reaction to Drug;   Vascular Endothelial Growth Factor Overexpression
Interventions: Drug: thalidomine;   Drug: tegafur-uracil
26 Recruiting Post-operative Pain Control After Pediatric Adenotonsillectomy
Conditions: Recurrent Tonsillitis;   Obstructive Sleep Apnea;   Sleep Disordered Breathing;   Adverse Reaction to Drug
Interventions: Drug: Ibuprofen;   Drug: Hydrocodone-Acetaminophen
27 Recruiting A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib and Erlotinib, in Non-small Cell Lung Cancer(NSCLC)Treatment
Conditions: Non-small Cell Lung Cancer (NSCLC);;   EGFR-TKI Resistant Mutation;;   EGFR-TKI Sensitizing Mutation;;   Germline Mutations
Intervention:
28 Recruiting Use of Public Health Surveillance Models in the French National Health System Database
Conditions: Atrial Fibrillation;   Anticoagulants;   Pharmacoepidemiology
Intervention: Drug: Dabigatran
29 Recruiting PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Conditions: Metastatic Breast Cancer;   Toxicity;   Neurotoxicity;   Drug Toxicity;   Adverse Drug Event
Intervention: Drug: ERIBULIN MESYLATE
30 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
31 Recruiting Acupuncture Prevents Chemobrain in Breast Cancer Patients
Conditions: Chemo-brain;   Drug-Related Side Effects and Adverse Reactions;   Mild Cognitive Impairment;   Breast Cancer
Interventions: Procedure: Dense cranial electroacupuncture stimulation;   Procedure: Body acupuncture;   Procedure: Least acupuncture stimulation;   Drug: Cytoxan-containing chemotherapy regimens
32 Recruiting Acute Care for Elders (ACE) Program at OHSU Hospital
Conditions: Delirium;   Age-Related Cognitive Decline;   Frail Elderly;   Hospital Acquired Pressure Ulcer;   Drug-Related Side Effects and Adverse Reactions
Intervention: Other: Acute Care of Elders focused geriatric care
33 Recruiting Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
Conditions: Central Line-Associated Bloodstream Infection (CLABSI);   Venous Thromboembolism;   Patient Fall;   Catheter-Associated Infection;   Severe Hypoglycemia;   Opioid-Related Severe Adverse Drug Event;   Hospital Acquired Pressure Ulcer;   Adverse Drug Event;   Severe Hospital Acquired Delerium;   Rapid Response Related to Arrhythmia
Intervention: Behavioral: Patient Safety health information technology
34 Recruiting Divided Drug Delivery
Condition: Hospitalized for Voluntary Drug Intoxication
Interventions: Other: Weekly divided delivery;   Other: Monthly divided delivery
35 Recruiting Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials
Conditions: Toxicity, Drug;   Maculopathy
Intervention: Device: spectral domain optical coherence tomography C-scan and multifocal electroretinogram
36 Recruiting High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs
Conditions: Self Efficacy;   Drug Toxicity
Intervention: Drug: Erlotinib or Gefitinib
37 Recruiting Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Condition: Genetics of Drug Metabolism
Intervention:
38 Recruiting Genetics of QT Prolongation With Antiarrhythmics
Conditions: Long QT Syndrome;   Drug Toxicity
Intervention: Drug: Dofetilide and/or sotalol
39 Recruiting Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients
Condition: Adrenal Insufficiency
Intervention: Other: ACTH stimulation test
40 Recruiting Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
Conditions: Renal Insufficiency,Chronic;   Hiv;   Therapeutic Agent Toxicity
Interventions: Drug: tenofovir alafenamide;   Drug: abacavir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.